JMCCX
Price
$60.60
Change
+$0.24 (+0.40%)
Updated
Sep 29 closing price
Net Assets
5.74B
VIMSX
Price
$80.06
Change
+$0.22 (+0.28%)
Updated
Sep 29 closing price
Net Assets
199.16B
Interact to see
Advertisement

JMCCX vs VIMSX

Header iconJMCCX vs VIMSX Comparison
Open Charts JMCCX vs VIMSXBanner chart's image
JPMorgan Mid Cap Equity C
Price$60.60
Change+$0.24 (+0.40%)
VolumeN/A
Net Assets5.74B
Vanguard Mid Cap Index Investor
Price$80.06
Change+$0.22 (+0.28%)
VolumeN/A
Net Assets199.16B
JMCCX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JMCCX vs. VIMSX commentary
Sep 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMCCX is a Buy and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 199B vs. JMCCX (5.74B). VIMSX pays higher dividends than JMCCX: VIMSX (1.35) vs JMCCX (0.00). JMCCX was incepted earlier than VIMSX: JMCCX (16 years) vs VIMSX (27 years). JMCCX (1.72) is less costly to investors than VIMSX (0.17). JMCCX is a more actively managed with annual turnover of: 38.00 vs. VIMSX (16.00). JMCCX has a lower initial minimum investment than VIMSX: JMCCX (1000) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 11.21 vs. JMCCX (2.29). VIMSX return over 5 years is better than : 67.48 vs. JMCCX (25.38).
JMCCXVIMSXJMCCX / VIMSX
Total Expense Ratio1.590.17935%
Annual Report Gross Expense Ratio1.720.171,012%
Fund Existence16 years27 years-
Gain YTD5.37710.84550%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets5.74B199B3%
Annual Yield % from dividends0.001.35-
Returns for 1 year2.2911.2120%
Returns for 3 years39.2756.4070%
Returns for 5 years25.3867.4838%
Returns for 10 years41.65151.1628%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRPT18.820.46
+2.51%
Sarepta Therapeutics
MOH192.950.97
+0.51%
Molina Healthcare
SWBI9.69-0.01
-0.10%
Smith & Wesson Brands
AIHS2.20-0.12
-4.97%
Senmiao Technology Limited
BLNE3.79-0.25
-6.19%
Beeline Holdings Inc